Protokinetix Inc (PKTX) financial statements (2021 and earlier)

Company profile

Business Address 412 MULBERRY STREET
MARIETTA, OH 45750
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments37729050424136110214
Cash and cash equivalents37729050424136110214
Prepaid expense111462211162
Total current assets:37830054946137122277
Noncurrent Assets
Intangible assets, net (including goodwill)208192193189188179161
Intangible assets, net (excluding goodwill)208192193189188179161
Total noncurrent assets:208192193189188179161
TOTAL ASSETS:586492742235325300438
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2655717955
Other undisclosed accounts payable and accrued liabilities2655717955
Total current liabilities:2655717955
Noncurrent Liabilities
Total liabilities:2655717955
Stockholders' equity
Stockholders' equity attributable to parent560487737164246295433
Common stock1111111
Additional paid in capital36,10733,57933,23731,89531,59531,45031,216
Accumulated deficit(35,548)(33,094)(32,502)(31,733)(31,350)(31,157)(30,785)
Total stockholders' equity:560487737164246295433
TOTAL LIABILITIES AND EQUITY:586492742235325300438

Income statement (P&L) ($ in thousands)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Operating expenses(2,454)(592)(769)(98)(197)(372)(343)
Operating loss:(2,454)(592)(769)(98)(197)(372)(343)
Other undisclosed loss from continuing operations before equity method investments, income taxes    (0)  
Loss before gain (loss) on sale of properties:(2,454)(592)(769)(98)(197)(372)(343)
Other undisclosed net income (loss)0(0)     
Net loss:(2,454)(592)(769)(98)(197)(372)(343)
Other undisclosed net income (loss) attributable to parent  0(284)3(0)(2)
Net loss available to common stockholders, diluted:(2,454)(592)(769)(382)(194)(372)(344)

Comprehensive Income ($ in thousands)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net loss:(2,454)(592)(769)(98)(197)(372)(343)
Comprehensive loss, net of tax, attributable to parent:(2,454)(592)(769)(98)(197)(372)(343)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: